Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Locations


Orders Processing,
Shipping & Receiving,
Warehouse

2 Shaker Rd Suites
B001/B101
Shirley, MA 01464


Production Lab

Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036

Telephone Numbers



Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565

Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C58109-100 100 Tests $485 
Antibody

Monoclonal Mouse anti‑Human SLC44A1 / CD92 Antibody (clone VIM‑15b, RPE, C‑Terminus) LS‑C58109

Monoclonal Mouse anti‑Human SLC44A1 / CD92 Antibody (clone VIM‑15b, RPE, C‑Terminus) LS‑C58109

Note: This antibody replaces LS-C58110
Antibody:
SLC44A1 / CD92 Mouse anti-Human Monoclonal (C-Terminus) (RPE) (VIM-15b) Antibody
Application:
Flo
Reactivity:
Human
Format:
R. Phycoerythrin, Unmodified
Other formats:
Price
Catalog Number
$485
LS-C58109-100
Toll Free North America
206-374-1102
For Research Use Only

Overview

Antibody:
SLC44A1 / CD92 Mouse anti-Human Monoclonal (C-Terminus) (RPE) (VIM-15b) Antibody
Application:
Flo
Reactivity:
Human
Format:
R. Phycoerythrin, Unmodified
Other formats:

Specifications

Description
CD92 antibody LS-C58109 is an RPE-conjugated mouse monoclonal antibody to human CD92 (SLC44A1) (C-Terminus). Validated for Flow.
Target
Human SLC44A1 / CD92
Synonyms
SLC44A1 | CD92 antigen | CTL1 | RP11-287A8.1 | CD92 | CDW92 | CDW92 antigen | CHTL1
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG2b Monoclonal
Clone
VIM-15b
Conjugations
R. Phycoerythrin. Also available conjugated with FITC.
Purification
Affinity purified
Modifications
Unmodified
Immunogen
MV4-11 acute monocyte leukaemia cells
Epitope
C-Terminus
Specificity
Specific for the C-terminal variant of human CDw92 (isoform 3), also known as CTL1, a 70kD multi-pass membrane protein, expressed by monocytes, neutrophils, certain myeloid and T cell lines, and weakly by endothelial cells, fibroblasts and epithelial cells. CDw92 is a member of the choline transporter-like protein family, so called due to their involvement in the efficient supply/transport of the natural amine choline, a vital cell nutrient required for the synthesis of cell membrane phospholipid components and the neurotransmitter acetylcholine. Clone VIM-15b is reported to augment the LPS-induced production of IL-10 by monocyte-derived dendritic cells (Mo-DCs), and the reduced expression of CDw92 by Mo-DCs treated with ionomycin or calcium ionophore, can be reinduced in the presence of IL-10.
Applications
  • Flow Cytometry (1:1 - 1:10)
  • Applications tested for the base form of this product only
Usage
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. Flow Cytometry: Use 10 ul of the suggested working dilution to label 1x10^6 cells in 100 ul. Method sheets are available on request.
Presentation
PBS, 0.09% Sodium Azide, 5% Sucrose, 1% BSA
Reconstitution
Reconstitute with distilled water.
Storage
Store at 4°C. Do not freeze. Store undiluted. Protect from light. Microcentrifugation recommended if solution contains precipitate.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About SLC44A1 / CD92
Q8WWI5 NM_080546 NP_536856.2

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 4/16/2024